ARTICLE | Company News
Medarex, Zycos deal
January 28, 2002 8:00 AM UTC
The companies will develop and commercialize antibodies against targets identified by Zycos. MEDX will contribute its UltiMAb Human Antibody Development System, while Zycos will use its Canvas protein...